GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 111 filers reported holding GENOMIC HEALTH INC in Q2 2014. The put-call ratio across all filers is 5.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $10,906,000 | -48.3% | 318,887 | -51.4% | 0.95% | +4.7% |
Q3 2017 | $21,076,000 | +96.5% | 656,786 | +99.3% | 0.91% | -4.1% |
Q2 2017 | $10,728,000 | +15.5% | 329,585 | +11.7% | 0.94% | +4.1% |
Q1 2017 | $9,288,000 | +33.1% | 294,962 | +24.3% | 0.91% | +10.7% |
Q4 2016 | $6,976,000 | +9.0% | 237,371 | +7.2% | 0.82% | -1.6% |
Q3 2016 | $6,402,000 | +19.8% | 221,354 | +7.3% | 0.83% | +6.9% |
Q2 2016 | $5,342,000 | +16.8% | 206,291 | +11.8% | 0.78% | +8.0% |
Q1 2016 | $4,572,000 | -27.3% | 184,586 | +3.3% | 0.72% | -30.7% |
Q4 2015 | $6,293,000 | +24.5% | 178,769 | -25.1% | 1.04% | +23.6% |
Q3 2015 | $5,053,000 | -9.8% | 238,797 | +18.5% | 0.84% | -3.4% |
Q2 2015 | $5,599,000 | +13.3% | 201,490 | +24.5% | 0.87% | +12.7% |
Q1 2015 | $4,943,000 | +2.5% | 161,796 | +7.2% | 0.77% | -5.5% |
Q4 2014 | $4,824,000 | +53.2% | 150,896 | +35.6% | 0.82% | +23.9% |
Q3 2014 | $3,149,000 | +15.3% | 111,244 | +11.6% | 0.66% | +21.3% |
Q2 2014 | $2,731,000 | – | 99,669 | – | 0.54% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,150,000 | $68,736,000 | 4.57% |
Baker Brothers Advisors | 13,656,318 | $436,592,000 | 4.46% |
NORTH TIDE CAPITAL, LLC | 1,500,000 | $47,955,000 | 3.22% |
Motley Fool Wealth Management, LLC | 72,732 | $2,325,000 | 1.36% |
Tributary Capital Management, LLC | 150,896 | $4,824,000 | 0.82% |
Champlain Investment Partners, LLC | 1,217,175 | $38,913,000 | 0.62% |
Motley Fool Asset Management LLC | 71,935 | $2,300,000 | 0.43% |
IRONBRIDGE CAPITAL MANAGEMENT LP | 440,410 | $14,080,000 | 0.39% |
CATAPULT CAPITAL MANAGEMENT LLC | 35,000 | $1,119,000 | 0.28% |
Spark Investment Management LLC | 51,100 | $1,633,000 | 0.27% |